Oropharyngeal Neoplasm: Clinical Trials

1 trial for Oropharyngeal Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Oropharyngeal Neoplasm: new trials by email Literature Review of Oropharyngeal Neoplasm trials Research Report on Oropharyngeal Neoplasm

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Treatment
Laboratory Biomarker Analysis, Metformide Hydrochloride/Pioglitazone Hydrochloride Extended-Release Tablet, Pharmacological Study - Oral Cavity Neoplasm, Oropharyngeal Neoplasm
Phase 2TerminatedNational Cancer Institute (NCI)62018-05-312023-03-08

Narrower conditions

Mouth Neoplasms (1)  ·  Oropharyngeal Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Broader conditions

Carcinoma (1)  ·  Carcinoma, Squamous Cell (1)  ·  Head and Neck Neoplasms (1)  ·  Mouth Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Otorhinolaryngologic Diseases (1)  ·  Otorhinolaryngologic Neoplasms (1)  ·  Pharyngeal Diseases (1)  ·  Pharyngeal Neoplasms (1)  ·  Stomatognathic Diseases (1)

Sponsors

National Cancer Institute (NCI) (1)

Countries

United States (1)

Top investigators

Frank G Ondrey (1)

NIH funding

N01CN00033 (1), P30CA014520 (1)